Bristol-Myers Squibb CompanyBMYNYSE
LOADING
|||
EPS Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
68.75%
↓ 45% below average
Average (39q)
125.89%
Historical baseline
Range
High:3308.45%
Low:-777.01%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 68.75% |
| Q2 2025 | -47.11% |
| Q1 2025 | 3308.45% |
| Q4 2024 | -94.08% |
| Q3 2024 | -27.71% |
| Q2 2024 | 114.09% |
| Q1 2024 | -777.01% |
| Q4 2023 | -7.45% |
| Q3 2023 | -5.05% |
| Q2 2023 | -8.33% |
| Q1 2023 | 12.50% |
| Q4 2022 | 28.00% |
| Q3 2022 | 11.94% |
| Q2 2022 | 11.67% |
| Q1 2022 | -45.45% |
| Q4 2021 | 57.14% |
| Q3 2021 | 48.94% |
| Q2 2021 | -47.78% |
| Q1 2021 | 120.22% |
| Q4 2020 | -636.14% |
| Q3 2020 | 2307.45% |
| Q2 2020 | 88.94% |
| Q1 2020 | 38.18% |
| Q4 2019 | -166.27% |
| Q3 2019 | -5.68% |
| Q2 2019 | -16.19% |
| Q1 2019 | 43.84% |
| Q4 2018 | -37.07% |
| Q3 2018 | 404.35% |
| Q2 2018 | -74.73% |
| Q1 2018 | 164.08% |
| Q4 2017 | -373.08% |
| Q3 2017 | -7.14% |
| Q2 2017 | -41.05% |
| Q1 2017 | 79.25% |
| Q4 2016 | -26.39% |
| Q3 2016 | 2.86% |
| Q2 2016 | -2.78% |
| Q1 2016 | 700.00% |
| Q4 2015 | -128.57% |